Belluscura
London
About Belluscura
Belluscura is a medical device company that focused on novel oxygen-based treatment platforms. They are a license and develop proprietary technologies that can be applied across a range of treatment possibilities. Belluscura is focused on disruptive treatment platforms so that their technology can be adapted and applied in a wide range of markets beyond those traditionally applied to a single product or product line. Belluscura was founded in 2015 and is based in London, Farringdon.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.6M
- Funding stage: IPO
- Last round: Series Unknown (Mar 2019)
- Ticker: lse:BELL
- Website: belluscura.com
- Phone: 1-214-396-8313
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/belluscura-28977 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.